Skip to main content Accessibility help
×
Home

Pertussis: An Underappreciated Risk for Nosocomial Outbreaks

  • David J. Weber (a1) and William A. Rutala (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Pertussis: An Underappreciated Risk for Nosocomial Outbreaks
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Pertussis: An Underappreciated Risk for Nosocomial Outbreaks
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Pertussis: An Underappreciated Risk for Nosocomial Outbreaks
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

Corresponding author

547 Burnett-Womack, CB #7030, Division of Infectious Diseases, UNC at Chapel Hill, Chapel Hill, NC 27599-7030

References

Hide All
1.Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1996. MMWR 1996;45(53):10, 4647.
2.Mortimer, EA. Pertussis and its prevention: a family affair. J Infect Dis 1990;161:473479.
3.Ivanoff, B, Robertson, SE. Pertussis: a worldwide problem. Dev Biol Stand 1997;89:313.
4.Cherry, JD. The role of Bordetella pertussis infections in adults in the epidemiology of pertussis. Dev Biol Stand 1997;89:181186.
5.Mink, CM, Cherry, JD, Christenson, P, Lewis, K, Pineda, E, Shilan, D, et al.A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464471.
6.Jansen, DL, Gray, GC, Putnam, SD, Lynn, F, Meade, BD. Evaluation of pertussis in US Marine Corps trainees. Clin Infect Dis 1997;25:10991107.
7.Nenning, ME. Shinefield, HR, Edwards, KM, Black, SB, Fireman, BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:16721674.
8.Aoyama, T, Takeuchi, Y, Groto, A, Iwai, H, Murase, Y, Iwata, T. Pertussis in adults. American Journal of Diseases in Children 1992;146:163166.
9.Schmitt-Grohe, S, Cherry, JD, Heininger, U, Uberall, MA, Pineda, E, Stehr, K. Pertussis in German adults. Clin Infect Dis 1995;21:860866.
10.Wirsing von Konig, CH, Postels-Multani, S, Bock, HL, Schmitt, HJ. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995;346:13261329.
11.Deen, JL, Mink, CM, Cherry, JD, Christenson, PD, Pineda, EF, Lewis, K, et al.Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995;21:12111219.
12.Postels-Multani, S, Schmitt, HJ, Wirsing von Konig, CH, Bock, HL, Bogaerts, H. Symptoms and complications of pertussis in adults. Infection 1995;23:139142.
13.Long, SS, Welkon, CJ, Clark, JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990;161:480486.
14.Christie, CDC, Baltimore, RS. Pertussis in neonates. American Journal of Diseases in Children 1989;143:11991202.
15.Steketee, RW, Burstyn, DG, Wassilak, SG, Adkins, WN Jr, Polyak, MB, Davis, JP, et al.A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis 1988;157:441449.
16.Hoppe, JE. Update on epidemiology, diagnosis, and treatment of pertussis. Eur J Clin Microbiol Infect Dis 1996;15:189193.
17.Black, S. Epidemiology of pertussis. Pediatr Infect Dis J 1997;16:S85S89.
18.Haiduven, DJ, Hench, CP, Simpkins, SM, Stevens, DA. Standardized management of patients and employees exposed to pertussis. Infect Control Hosp Epidemiol 1998;19:861864.
19.Kurt, TL, Yeager, AS, Guenette, S, Dunlop, S. Spread of pertussis by hospital staff. JAMA 1972;221:264267.
20.Linnemann, CC Jr, Ramundo, N, Perlstein, PH, Minton, SD, Englender, GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975;2:540543.
21.Valenti, WM, Pincus, PH, Messner, MK. Nosocomial pertussis: possible spread by a hospital visitor. American Journal of Diseases in Children 1980;134:520521.
22.Fisher, MC, Long, SS, McGowan, KL, Kaselis, E, Smith, DG. Outbreak of pertussis in a residential facility for handicapped people. J Pediatr 1989;114:934939.
23.Addiss, DG, Davis, JP, Meade, BD, Burstyn, DG, Melssner, M, Zastrow, JA, et al.A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 1991;164:704710.
24.Tanaka, Y, Fujinaga, K, Goto, A, Iwai, H, Aoyama, T, Murase, Y, et al.Outbreak of pertussis in a residential facility for handicapped people. Dev Biol Standard 1991;73:329332.
25.Christie, CD, Glover, AM, Wilke, MJ, Marx, ML, Reising, SF, Hutchinson, NM. Containment of pertussis in the regional pediatric hospital during the greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995;16:556563.
26.Deville, JG, Cherry, JD, Christenson, PD, Pineda, E, Leach, CT, Kuhis, TL, et al.Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995;21:639642.
27.Bolyard, EA, Tablan, OC, Williams, WW, Pearson, ML, Shapiro, CN, Deitchman, SD, et al.Guideline for infection control in health care personnel, 1998. Am J Infect Control 1998;26:289354.
28.Rutala, WA, Weber, DJ. Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol 1994;15:411415.
29.Strebel, P. Pertussis. In: APIC Infection Control and Applied Epidemiology. Principles and Practice. St Louis, MO: Mosby; 1996:71.171.5.
30.Bass, JW, Crast, FW, Kotheimer, JB, Mitchell, IA. Susceptibility of Borde-tella pertussis to nine antimicrobial agents. American Journal of Diseases in Children 1969;117:276280.
31.Hoppe, JE, Haug, A. Antimicrobial susceptibility of Bordetella pertussis, part I: infection 1988;16:126130.
32.American Academy of Pediatrics. Pertussis In: Peter, G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics 1997:394407.
33.Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-7):123.
34.Cherry, JD. Nosocomial pertussis in the nineties. Infect Control Hosp Epidemiol 1995;16:553555.
35.Mortimer, EA Jr.Pertussis and pertussis vaccine. Adv Ped Infect Dis 1990;5:133.
36.Waggoner-Fountain, L, Hayden, GF. Pertussis in primary care practice. Recent advances in diagnosis, treatment, and prevention. Prim Care 1996;23:793804.
37.Hoppe, JE, Bryskier, A. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). Antimicrob Agents Chemother 1998;42:965966.
38.Brett, M, Short, P, Beatson, S. The comparative in-vitro activity of rox-ithromycin and other antibiotics against Bordetella pertussis. J Antimicrob Chem 1998;41(suppl B):2327.
39.Sprauer, MA, Cochi, SL, Zell, ER, Sutter, RW, Mullen, JR, Englender, SJ, et al.Prevention of secondary transmission of pertussis in households with early use of erythromycin. American Journal of Diseases in Children 1992;146:177181.
40.De Serres, G, Boulianne, N, Duval, B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr Infect Dis J 1995;14:969975.
41.Shefer, A, Dales, L, Nelson, M, Werner, B, Baron, R, Jackson, R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 1995;171:10531056.
42.Dodhia, H, Miller, E. Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. Epidemiol Infect 1998;120:143149.
43.Lewis, K, Saubolle, MA, Tenover, FC, Rudinsky, MF, Barbour, SD, Cherry, JD. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 1995;14:388391.
44.Korgenski, EK, Daly, JA. Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. J Clin Microbiol 1997;35:29892991.
45.Hoppe, JE, Rahimi-Galougahi, E, Seibert, G. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levfloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem. Antimicrob Agents Chemother 1996;40:807808.
46.Hoppe, JE, Halm, U, Hagedorn, HJ, Kraminer-Hagedorn, A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 1989;17:227231.
47.Aoyama, T, Sunakawa, K, Iwata, S, Takeuchi, Y, Fujii, R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J Pediatr 1996;129:761764.
48.Halperin, SA, Bortolussi, R, Langley, JM, Miller, B, Eastwood, BJ. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics 1997;100:6571.
49.Centers for Disease Control and Prevention. Immunization of healthcare workers: recommendations to the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR-18):141.
50.Pichichero, ME. Acellular pertussis vaccines: towards an improved safety profile. Drug Safety 1996;15:311324.
51.Edwards, KM, Decker, MD, Graham, BS, Mezzatesta, J, Scott, J, Hackell, J. Adult immunization with acellular pertussis vaccine. JAMA 1993;269:5356.
52.Tommaso, AD, Bartalini, M, Peppoloni, S, Podda, A, Rappuoli, R, De Magistris, MT. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. Vaccine 1997;15:12181224.
53.Keitel, WA, Edwards, KM. Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect 1995;10:5157.
54.Muller, FC, Hoppe, JE, von Konig, CW. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997;35:24352443.
55.Reizenstein, E, Lindberg, L, Mollby, R, Hallander, HO. Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol 1996;34:810815.
56.Reizenstein, E. Diagnostic polymerase chain reaction. In: Brown, F, Greco, D, Mastrantonio, P, Salmaso, S, Wassilak, S. Pertussis Vaccine Trials. Dev Biol Stand. Basel, Karger, 1997;89:247254.
57.Erlandsson, A, Backman, A, Tornqvist, E, Olsen, P. PCR assay or culture for diagnosis of Bordetella pertussis in the routine diagnostic laboratory? J Infect 1997;35:221224.
58.Matlow, AG, Nelson, S, Wray, R, Cox, P. Nosocomial acquisition of pertussis diagnosed by polymerase chain reaction. Infect Control Hosp Epidemiol 1997;18:715716.
59.Edelman, K, Nikkari, S, Ruuskanen, O, He, Q, Viljanen, M, Mertsola, J. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr Infect Dis J 1996;15:5457.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed